-
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer
28 Mar 2024 16:05 GMT
… . Sjogren. “I have dedicated my career to designing effective commercial organizations … senior leadership roles at Medivation, Human Genome Sciences, Genentech, and Centocor. She received …
-
Morphic Therapeutic Taps Simon Cooper as Chief Medical Officer
19 Mar 2024 21:20 GMT
… in psoriasis.
Earlier in this career, Cooper held roles of increasing … Research, Napp Pharmaceutical Research, Roche, Human Genome Sciences and MedImmune.
Cooper holds a …
-
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
19 Mar 2024 12:00 GMT
… in psoriasis. Earlier in this career, Dr. Cooper held roles of … Research, Napp Pharmaceutical Research, Roche, Human Genome Sciences and MedImmune. Dr Cooper holds …
-
On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough
26 Feb 2024 22:57 GMT
… background, having worked at Human Genome Sciences earlier in his career. Masoud was appointed …
-
MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
11 Dec 2023 21:05 GMT
… . Mr. Masoud started his biopharmaceutical career as a research associate with … , a Maravai company, before joining Human Genome Sciences as Director and Corporate Counsel … company. During his tenure at Human Genome Sciences and Wellstat, Mr. Masoud supported …
-
Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer
19 Oct 2023 13:05 GMT
… .
Dr. Lechleider began his biotech career at MedImmune (an Astra Zeneca … Human Genome Sciences and Macrogenics before heading development at Seagen. Prior to his career …
-
The CFO at one of the largest law firms in the U.S. shares his philosophy for thriving as a self-described introvert: ‘I do not do work dinners’
21 Aug 2023 13:43 GMT
… says.
Earlier in his career, Washington was a finance … Mae. His first CFO job was as finance chief … Transplace. Earlier in his career, Oppenheimer worked at Coatue … Biotherapeutics, Lehman Brothers, and Human Genome Sciences.
Overheard
"I think what …
-
Autolus Therapeutics plc (NASDAQ:AUTL) Q2 2023 Earnings Call Transcript
07 Aug 2023 20:38 GMT
… and operational roles at Moderna, Human Genome Sciences, and Amgen. Rob is … Officer. She brings a long career in oncology development, medical affairs … at companies like Human Genome Sciences and others. And particularly at Human Genome Sciences, Miranda led …
-
Autolus Therapeutics announces appointment of Robert F. Dolski as Chief Financial Officer
19 Jul 2023 11:00 GMT
… stage gene therapy programs. At Human Genome Sciences, Inc., Miranda led program … , Forum Pharmaceuticals, Inc., and Human Genome Sciences, Inc., prior to its acquisition … Virginia University, she started her career at Human Genome Sciences, Inc. She spent 10 …